Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 250 results in range #1 to #250.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. ICRP Glossary‏‎ (267 revisions)
  2. Application of ionising radiation in healthcare‏‎ (98 revisions)
  3. Information for healthcare providers‏‎ (80 revisions)
  4. Information for patients, family members, carers and the public‏‎ (62 revisions)
  5. System Of Radiation Protection Overview‏‎ (43 revisions)
  6. Guide to Radiological Protection in Healthcare‏‎ (43 revisions)
  7. General Information on Radon‏‎ (31 revisions)
  8. Main Page‏‎ (29 revisions)
  9. Information for healthcare providers (old)‏‎ (24 revisions)
  10. Information for patients, family members, carers and the public (old)‏‎ (24 revisions)
  11. Application of ionising radiation in healthcare (old)‏‎ (24 revisions)
  12. Effective dose‏‎ (23 revisions)
  13. Radon For Governments and Employers‏‎ (23 revisions)
  14. Radon For Homeowners and Residents‏‎ (22 revisions)
  15. The System of Radiological Protection‏‎ (21 revisions)
  16. Guide to Radon‏‎ (19 revisions)
  17. Tissue weighting factor‏‎ (17 revisions)
  18. List of ICRP Publications on Radiological Protection in Healthcare‏‎ (16 revisions)
  19. ICRP publications‏‎ (14 revisions)
  20. System of radiation protection module 2‏‎ (14 revisions)
  21. Quotes from Publications on the System of Radiological Protection‏‎ (13 revisions)
  22. Equivalent dose‏‎ (11 revisions)
  23. Absorbed, Equivalent, and Effective Dose‏‎ (10 revisions)
  24. Air-kerma rate constant‏‎ (9 revisions)
  25. Fundamental Principles of Radiological Protection‏‎ (9 revisions)
  26. Absorbed dose‏‎ (9 revisions)
  27. Objectives of Radiological Protection‏‎ (9 revisions)
  28. Organ/tissue absorbed dose‏‎ (8 revisions)
  29. Effects of Exposure‏‎ (8 revisions)
  30. Prudence‏‎ (8 revisions)
  31. Beneficence‏‎ (8 revisions)
  32. Collective effective dose‏‎ (7 revisions)
  33. Exposure Categories and Situations‏‎ (6 revisions)
  34. Alimentary tract‏‎ (6 revisions)
  35. Investigation level‏‎ (6 revisions)
  36. ICRPædia Guides‏‎ (6 revisions)
  37. Accelerated fractionation‏‎ (6 revisions)
  38. Justice‏‎ (6 revisions)
  39. Linear energy transfer‏‎ (6 revisions)
  40. Dose coefficient‏‎ (5 revisions)
  41. Sources of Radiation Exposure‏‎ (5 revisions)
  42. Quality factor‏‎ (5 revisions)
  43. Principle of optimisation‏‎ (5 revisions)
  44. Absorbed fraction‏‎ (5 revisions)
  45. ICRPædia Guide to the System of Radiological Protection‏‎ (5 revisions)
  46. Justification‏‎ (5 revisions)
  47. Protection quantities‏‎ (5 revisions)
  48. Kerma‏‎ (5 revisions)
  49. Types of materials‏‎ (5 revisions)
  50. Radiation weighting factor‏‎ (5 revisions)
  51. Air-kerma, entrance surface‏‎ (5 revisions)
  52. Fractionation sensitivity‏‎ (4 revisions)
  53. Air kerma at the patient entrance reference point‏‎ (4 revisions)
  54. Optimisation‏‎ (4 revisions)
  55. High linear energy transfer radiation‏‎ (4 revisions)
  56. Sievert‏‎ (4 revisions)
  57. Computed tomography dose index‏‎ (4 revisions)
  58. Non-maleficence‏‎ (4 revisions)
  59. Direct bioassay‏‎ (4 revisions - redirect page)
  60. S coefficient (radiation weighted)‏‎ (4 revisions)
  61. Bioassay‏‎ (4 revisions)
  62. Calculating Radon Doses‏‎ (4 revisions)
  63. Alpha decay‏‎ (4 revisions)
  64. Effective charge number‏‎ (4 revisions)
  65. Mass median diameter‏‎ (4 revisions)
  66. Math‏‎ (4 revisions)
  67. Programmed cell death‏‎ (4 revisions)
  68. Effective half-life‏‎ (4 revisions)
  69. Averted dose‏‎ (4 revisions)
  70. Protective action‏‎ (4 revisions)
  71. Reference Animal and Plant‏‎ (4 revisions)
  72. Forbiddenness‏‎ (4 revisions)
  73. Aerodynamic diameter‏‎ (4 revisions)
  74. ICRP‏‎ (4 revisions)
  75. Kp index‏‎ (4 revisions)
  76. Diagnostic reference level‏‎ (4 revisions)
  77. Source-related assessment‏‎ (4 revisions)
  78. Reference bioassay function‏‎ (4 revisions)
  79. Air-kerma, product‏‎ (4 revisions)
  80. Risk‏‎ (4 revisions)
  81. Senescence‏‎ (4 revisions)
  82. Coster-Kronig transition‏‎ (3 revisions)
  83. Uptake‏‎ (3 revisions)
  84. Granulocyte colony-stimulating factor‏‎ (3 revisions)
  85. Utilitarian ethics‏‎ (3 revisions)
  86. Operational quantity‏‎ (3 revisions)
  87. Emergency preparedness‏‎ (3 revisions)
  88. Gray‏‎ (3 revisions)
  89. Value judgement‏‎ (3 revisions)
  90. Emergency procedures‏‎ (3 revisions)
  91. Absolute risk‏‎ (3 revisions)
  92. Auger transition‏‎ (3 revisions)
  93. Bystander effect‏‎ (3 revisions)
  94. Complex tissues‏‎ (3 revisions)
  95. Valvular heart disease‏‎ (3 revisions)
  96. Derived air concentration‏‎ (3 revisions)
  97. Dignity‏‎ (3 revisions)
  98. Personal dose equivalent‏‎ (3 revisions)
  99. Principle of justification‏‎ (3 revisions)
  100. Employer‏‎ (3 revisions)
  101. Radiofrequency ablation‏‎ (3 revisions)
  102. Activity median thermodynamic diameter‏‎ (3 revisions)
  103. Lifetime risk estimates‏‎ (3 revisions)
  104. Virtue ethics‏‎ (3 revisions)
  105. Growth fraction‏‎ (3 revisions)
  106. Iso-effect plots‏‎ (3 revisions)
  107. Voxel phantom‏‎ (3 revisions)
  108. Radiological Protection in Healthcare‏‎ (3 revisions - redirect page)
  109. Excretion rate (instantaneous)‏‎ (3 revisions)
  110. Extrathoracic airways‏‎ (3 revisions)
  111. Galactic cosmic radiation‏‎ (3 revisions)
  112. Growth hormone (somatotropin)‏‎ (3 revisions)
  113. ICRP Publication 103‏‎ (3 revisions)
  114. Isomers‏‎ (3 revisions)
  115. DNA damage signalling‏‎ (3 revisions)
  116. Organ dose equivalent‏‎ (3 revisions)
  117. Fairness‏‎ (3 revisions)
  118. Absorption‏‎ (3 revisions)
  119. Gamma ray‏‎ (3 revisions)
  120. Dose equivalent‏‎ (3 revisions)
  121. Field-size effect (Volume effect)‏‎ (3 revisions)
  122. Gastrointestinal syndrome‏‎ (3 revisions)
  123. Biomedical research volunteer‏‎ (3 revisions)
  124. Cardiomyopathy‏‎ (3 revisions)
  125. Dose limit‏‎ (3 revisions)
  126. Recovery‏‎ (3 revisions)
  127. Flexible tissues‏‎ (3 revisions)
  128. Guide to the System of Radiological Protection‏‎ (3 revisions)
  129. Autonomy‏‎ (3 revisions)
  130. Spread-out Bragg peak‏‎ (3 revisions)
  131. Constancy test‏‎ (3 revisions)
  132. Wisdom‏‎ (3 revisions)
  133. Dose‏‎ (3 revisions)
  134. Dose limits‏‎ (3 revisions)
  135. Fluence‏‎ (3 revisions)
  136. Target region‏‎ (3 revisions)
  137. DS02‏‎ (3 revisions)
  138. Fluoroscopically guided interventions‏‎ (3 revisions)
  139. Annual dose‏‎ (3 revisions)
  140. Contamination‏‎ (3 revisions)
  141. Dose of record (E)‏‎ (3 revisions)
  142. Accountability‏‎ (3 revisions)
  143. Half-life, physical‏‎ (3 revisions)
  144. Cell death‏‎ (3 revisions)
  145. Potential exposure‏‎ (3 revisions)
  146. Exponential survival curve‏‎ (3 revisions)
  147. Annual limit on intake‏‎ (3 revisions)
  148. Low Earth orbit‏‎ (3 revisions)
  149. X ray‏‎ (3 revisions)
  150. Dose per content function‏‎ (3 revisions)
  151. Equity‏‎ (3 revisions)
  152. Graded approach‏‎ (3 revisions)
  153. Rigidity threshold‏‎ (3 revisions)
  154. Unsealed source‏‎ (3 revisions)
  155. Xerostomia‏‎ (3 revisions)
  156. Fractionation‏‎ (3 revisions)
  157. Test‏‎ (3 revisions)
  158. Public exposure‏‎ (3 revisions)
  159. Active (red) bone marrow‏‎ (3 revisions)
  160. Granulocyte-macrophage colony-stimulating factor‏‎ (3 revisions)
  161. Interphase death‏‎ (3 revisions)
  162. Latent time/period or latency interval‏‎ (2 revisions)
  163. Class SR-2 gases‏‎ (2 revisions)
  164. Low level waste‏‎ (2 revisions)
  165. Committed equivalent dose‏‎ (2 revisions)
  166. Dichotomous‏‎ (2 revisions)
  167. Dose rate effectiveness factor‏‎ (2 revisions)
  168. Qualified expert‏‎ (2 revisions)
  169. Emergency plan‏‎ (2 revisions)
  170. Radioactive substance‏‎ (2 revisions)
  171. Ethics‏‎ (2 revisions)
  172. ALARA‏‎ (2 revisions)
  173. Reference biokinetic model‏‎ (2 revisions)
  174. Relocation‏‎ (2 revisions)
  175. Risk coefficient‏‎ (2 revisions)
  176. Hierarchical tissues‏‎ (2 revisions)
  177. Area monitoring‏‎ (2 revisions)
  178. Individual monitoring‏‎ (2 revisions)
  179. Benthic‏‎ (2 revisions)
  180. Source term‏‎ (2 revisions)
  181. Bronchial region‏‎ (2 revisions)
  182. Substantial radiation dose level‏‎ (2 revisions)
  183. Clearance‏‎ (2 revisions)
  184. Transfer rate‏‎ (2 revisions)
  185. Multi-detector computed tomography‏‎ (2 revisions)
  186. Deontological Ethics‏‎ (2 revisions)
  187. Differentiation‏‎ (2 revisions)
  188. Percutaneous coronary intervention‏‎ (2 revisions)
  189. Prevailing circumstances‏‎ (2 revisions)
  190. Radon Recommendations for Authorities‏‎ (2 revisions)
  191. Reference individual‏‎ (2 revisions)
  192. Activity‏‎ (2 revisions)
  193. Remedial action‏‎ (2 revisions)
  194. ICRPædia Guide to Dose Coefficients‏‎ (2 revisions)
  195. High level waste‏‎ (2 revisions)
  196. Intervention Level‏‎ (2 revisions)
  197. Clearance level‏‎ (2 revisions)
  198. Lymphatic system‏‎ (2 revisions)
  199. Transforming growth factor‏‎ (2 revisions)
  200. Pericarditis‏‎ (2 revisions)
  201. Dose constraint‏‎ (2 revisions)
  202. Principle of application of dose limits‏‎ (2 revisions)
  203. Early normal tissue responses‏‎ (2 revisions)
  204. Radioactivity‏‎ (2 revisions)
  205. Radon Recommendations for Workplaces‏‎ (2 revisions)
  206. Reference level‏‎ (2 revisions)
  207. Remediation‏‎ (2 revisions)
  208. Risk of Exposure to Radon‏‎ (2 revisions)
  209. Beta-minus decay‏‎ (2 revisions)
  210. South Atlantic anomaly‏‎ (2 revisions)
  211. Interventional procedure‏‎ (2 revisions)
  212. Lifetime risk‏‎ (2 revisions)
  213. Macrophage colony stimulating factor‏‎ (2 revisions)
  214. Multiplicative risk projection model‏‎ (2 revisions)
  215. Cumulative dose‏‎ (2 revisions)
  216. Dose conversion coefficient‏‎ (2 revisions)
  217. Edema‏‎ (2 revisions)
  218. Excess relative risk‏‎ (2 revisions)
  219. Exposure situation‏‎ (2 revisions)
  220. Repopulation‏‎ (2 revisions)
  221. Growth factor‏‎ (2 revisions)
  222. Alimentary tract transfer factor‏‎ (2 revisions)
  223. Routine monitoring‏‎ (2 revisions)
  224. ICRPædia Guide to Radon‏‎ (2 revisions)
  225. Beta-plus decay‏‎ (2 revisions)
  226. Special (non-routine) monitoring‏‎ (2 revisions)
  227. Calculating Doses from Intakes of Radionuclides‏‎ (2 revisions)
  228. Clonogenic cells‏‎ (2 revisions)
  229. Threshold dose for tissue reactions‏‎ (2 revisions)
  230. Magnetosphere‏‎ (2 revisions)
  231. Curie‏‎ (2 revisions)
  232. Effect Dose 50‏‎ (2 revisions)
  233. Endogeneous excretion‏‎ (2 revisions)
  234. Radiographer‏‎ (2 revisions)
  235. Exposure to Radon at Home‏‎ (2 revisions)
  236. GATA binding protein 2‏‎ (2 revisions)
  237. Representative organism (non-human biota)‏‎ (2 revisions)
  238. ICRPædia Guide to the Basics of Ionising Radiation‏‎ (2 revisions)
  239. Hormones‏‎ (2 revisions)
  240. Authorization‏‎ (2 revisions)
  241. Limitation of dose‏‎ (2 revisions)
  242. Clonogenic survival‏‎ (2 revisions)
  243. Transmission detection system‏‎ (2 revisions)
  244. Multistage tumorigenesis‏‎ (2 revisions)
  245. Cytokines‏‎ (2 revisions)
  246. Non-sphericity parameter‏‎ (2 revisions)
  247. Pharynx‏‎ (2 revisions)
  248. Acute radiation syndrome‏‎ (2 revisions)
  249. Representative person‏‎ (2 revisions)
  250. Safety‏‎ (2 revisions)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://icrpaedia.org/Special:MostRevisions"